February 16, 2020 / 1:37 PM / 2 months ago

BRIEF-Zhejiang Hisun Pharmaceutical says receives approval to start selling coronavirus treatment - company filing

Feb 16 (Reuters) - Zhejiang Hisun Pharmaceutical Co Ltd :

* RECEIVES APPROVAL TO START SELLING FAVIPIRAVIR AS POTENTIAL TREATMENT FOR NOVEL CORONAVIRUS - COMPANY FILING

* SAYS MUST STILL CONTINUE CLINICAL TRIALS AFTER FAVIPIRAVIR HITS MARKET AS POTENTIAL CORONAVIRUS TREATMENT - COMPANY FILING Source text in Chinese: here Further company coverage: (Reporting by Josh Horwitz; Editing by Alison Williams)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below